Methodological quality of systematic reviews on treatments for Alzheimer’s disease: a cross-sectional study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Methodological quality of systematic reviews on treatments for Alzheimer’s disease: a cross-sectional study ; volume:14 ; number:1 ; day:29 ; month:10 ; year:2022 ; pages:1-12 ; date:12.2022
Alzheimer's research & therapy ; 14, Heft 1 (29.10.2022), 1-12, 12.2022
- Urheber
-
Zhong, Claire C. W.
Zhao, Jinglun
Wong, Charlene H. L.
Wu, Irene X. Y.
Mao, Chen
Yeung, Jerry W. F.
Chung, Vincent C. H.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-022-01100-w
- URN
-
urn:nbn:de:101:1-2023011409055114022166
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhong, Claire C. W.
- Zhao, Jinglun
- Wong, Charlene H. L.
- Wu, Irene X. Y.
- Mao, Chen
- Yeung, Jerry W. F.
- Chung, Vincent C. H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatments in Alzheimer’s disease
New treatments in Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
New approaches to symptomatic treatments for Alzheimer’s disease
Study partners: essential collaborators in discovering treatments for Alzheimer’s disease
Correction to: New approaches to symptomatic treatments for Alzheimer’s disease
ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
Can Digital Technology Advance the Development of Treatments for Alzheimer’s Disease?
The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update
Physical activity monitoring in Alzheimer’s disease during sport interventions : a multi-methodological perspective
Therapeutic preference for Alzheimer’s disease treatments: a discrete choice experiment with caregivers and neurologists
Alzheimer’s Disease
Treatments in Alzheimer’s disease
New treatments in Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
New approaches to symptomatic treatments for Alzheimer’s disease
Study partners: essential collaborators in discovering treatments for Alzheimer’s disease
Correction to: New approaches to symptomatic treatments for Alzheimer’s disease
ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
Can Digital Technology Advance the Development of Treatments for Alzheimer’s Disease?
The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update
Physical activity monitoring in Alzheimer’s disease during sport interventions : a multi-methodological perspective
Therapeutic preference for Alzheimer’s disease treatments: a discrete choice experiment with caregivers and neurologists
Alzheimer’s Disease
Treatments in Alzheimer’s disease
New treatments in Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
New approaches to symptomatic treatments for Alzheimer’s disease
Study partners: essential collaborators in discovering treatments for Alzheimer’s disease
Correction to: New approaches to symptomatic treatments for Alzheimer’s disease
ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
Can Digital Technology Advance the Development of Treatments for Alzheimer’s Disease?
The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update
Physical activity monitoring in Alzheimer’s disease during sport interventions : a multi-methodological perspective
Therapeutic preference for Alzheimer’s disease treatments: a discrete choice experiment with caregivers and neurologists